197 related articles for article (PubMed ID: 37105934)
21. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.
Xie H; Yao J; Wang Y; Ni B
Drug Deliv; 2022 Dec; 29(1):1257-1271. PubMed ID: 35467477
[TBL] [Abstract][Full Text] [Related]
22. Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis.
Chu D; Li P; Li Y; Shi J; Huang S; Jiao P
Thorac Cancer; 2021 Nov; 12(21):2894-2906. PubMed ID: 34523261
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of circ-PIP5K1A overcomes resistance to cisplatin in ovarian cancer by miR-942-5p/NFIB axis.
Sheng H; Wang X
Anticancer Drugs; 2023 Feb; 34(2):214-226. PubMed ID: 36730637
[TBL] [Abstract][Full Text] [Related]
24. CircRNA OXCT1 promotes the malignant progression and glutamine metabolism of non-small cell lung cancer by absorbing miR-516b-5p and upregulating SLC1A5.
Luo H; Peng J; Yuan Y
Cell Cycle; 2023 May; 22(10):1182-1195. PubMed ID: 35482822
[TBL] [Abstract][Full Text] [Related]
25. Circ-ZKSCAN1 regulates FAM83A expression and inactivates MAPK signaling by targeting miR-330-5p to promote non-small cell lung cancer progression.
Wang Y; Xu R; Zhang D; Lu T; Yu W; Wo Y; Liu A; Sui T; Cui J; Qin Y; Dong Y; Leng X; Kong D; Du W; Huang Z; Su W; Yuan T; Sun X; Wang J; Jiao W
Transl Lung Cancer Res; 2019 Dec; 8(6):862-875. PubMed ID: 32010565
[TBL] [Abstract][Full Text] [Related]
26. Circ_0011292 Enhances Paclitaxel Resistance in Non-Small Cell Lung Cancer by Regulating miR-379-5p/TRIM65 Axis.
Guo C; Wang H; Jiang H; Qiao L; Wang X
Cancer Biother Radiopharm; 2022 Mar; 37(2):84-95. PubMed ID: 32833503
[No Abstract] [Full Text] [Related]
27. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
[TBL] [Abstract][Full Text] [Related]
28. Circ_0000735 enhances the proliferation, metastasis and glycolysis of non-small cell lung cancer by regulating the miR-635/FAM83F axis.
Tai G; Zhang M; Liu F
Exp Lung Res; 2021 Apr; 47(3):136-148. PubMed ID: 33560141
[TBL] [Abstract][Full Text] [Related]
29. Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5).
Wei D; Zeng J; Rong F; Xu Y; Wei R; Zou C
Bioengineered; 2022 Mar; 13(3):5126-5140. PubMed ID: 35170372
[TBL] [Abstract][Full Text] [Related]
30. Circular non-coding RNA circ_0072088 serves as a ceRNA, targeting the miR-1225-5p/WT1 axis to regulate non-small cell lung cancer cell malignant behavior.
Zhu X; Wan J; You X; Yang W; Zhao L
Thorac Cancer; 2023 Jul; 14(20):1969-1979. PubMed ID: 37220935
[TBL] [Abstract][Full Text] [Related]
31. Circular RNA circ-TSPAN4 promotes lung adenocarcinoma metastasis by upregulating ZEB1 via sponging miR-665.
Ying X; Zhu J; Zhang Y
Mol Genet Genomic Med; 2019 Dec; 7(12):e991. PubMed ID: 31573758
[TBL] [Abstract][Full Text] [Related]
32. Circular RNA Circ_0001777 Suppresses Lung Adenocarcinoma Progression In Vitro and In Vivo.
Zhu L; Liu Y; Tang H; Wang P
Biochem Genet; 2023 Apr; 61(2):704-724. PubMed ID: 36103059
[TBL] [Abstract][Full Text] [Related]
33. Circ-CUL2/microRNA-888-5p/RB1CC1 axis participates in cisplatin resistance in NSCLC via repressing cell advancement.
Chen H; Li F; Xue Q
Bioengineered; 2022 Feb; 13(2):2828-2840. PubMed ID: 35068326
[TBL] [Abstract][Full Text] [Related]
34. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis.
Zhang W; Song C; Ren X
Technol Cancer Res Treat; 2021; 20():1533033821990040. PubMed ID: 33511909
[TBL] [Abstract][Full Text] [Related]
35. Hsa_circ_0001361 facilitates the progress of lung adenocarcinoma cells via targeting miR-525-5p/VMA21 axis.
Shen HY; Shi LX; Wang L; Fang LP; Xu W; Xu JQ; Fan BQ; Fan WF
J Transl Med; 2021 Sep; 19(1):389. PubMed ID: 34507559
[TBL] [Abstract][Full Text] [Related]
36. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
Zhu X; Du J; Gu Z
Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
[TBL] [Abstract][Full Text] [Related]
37. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
Sui MH; Zhang WW; Geng DM; Sun DJ
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
[TBL] [Abstract][Full Text] [Related]
38. Circ_0074027 Contributes to Non-Small Cell Lung Cancer Progression by Upregulating
Yu C; Ying J; Yu K; Shen W; Jiang M
Cancer Biother Radiopharm; 2022 Mar; 37(2):73-83. PubMed ID: 32580576
[No Abstract] [Full Text] [Related]
39. Circular RNA PRMT5 confers cisplatin-resistance via miR-4458/REV3L axis in non-small-cell lung cancer.
Pang J; Ye L; Zhao D; Zhao D; Chen Q
Cell Biol Int; 2020 Dec; 44(12):2416-2426. PubMed ID: 32808744
[TBL] [Abstract][Full Text] [Related]
40. Circ-SNAP47 (hsa_circ_0016760) and miR-625-5p are regulators of WEE1 in regulation of chemoresistance, growth and invasion of DDP-tolerant NSCLC cells via ceRNA pathway.
Zou C; Rong F; Zeng Y; Zeng J; Wei R; Wei D
Environ Toxicol; 2022 Feb; 37(2):224-236. PubMed ID: 34664776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
